FREQ
Frequency Therapeutics Inc
Halal Rating :
Last Price
$37.25
Last updated:
Market Cap
-
7D Change
-2.36%
1 Year Change
-12.35%
Company Overview
Exchange
Next Earnings Date
Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics to activate a person's innate regenerative potential to restore function. The company's lead product candidate, FX-322, is designed to treat the underlying cause of sensorineural hearing loss. The company also has programs in multiple sclerosis and other degenerative diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Frequency Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.